Novo Nordisk is a global healthcare company with a long and strong history of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Novo Nordisk in Warsaw employs 200 employees in the Polish Affiliate and the Business Area Office, supporting the Eastern European countries.

Universal-Investment-Gesellschaft mbH is an investment company based in Frankfurt am Main. With 369 billion Euro assets under management, 1,000 institutional funds and private label funds and more than 650 employees Universal-Investment is one of the leading German investment firms. In 2014, the company ranked third, after Allianz Global Investors and DWS/DeAWM and before DekaBank.